Skip Navigation
Archive

NIAID Archive

Important note: Information on this page was accurate at the time of publication. This page is no longer being updated.
​​
NIH HHS News Release Logo

National Institute of Allergy and
Infectious Diseases (NIAID)
http://www.niaid.nih.gov

FOR IMMEDIATE RELEASE
Friday, November 30, 2001

Media Contact:
Jeff Minerd
(301) 402-1663

niaidnews@niaid.nih.gov

Skip Content Marketing
  • Share this:
  • submit to facebook
  • Tweet it
  • submit to reddit
  • submit to StumbleUpon
  • submit to Google +

Scientists Find Hidden Piece of Influenza Virus

For nearly 20 years, scientists have labored under the assumption that the influenza virus comprises only 10 protein molecules that form its structure and carry out its activities. However, this week in Nature Medicine researchers report finding a new, "hidden" influenza virus protein. This protein may kill immune system cells that fight the virus, thereby contributing to the virus's potency, the researchers say.

"We believe this is a groundbreaking finding, although we're not yet sure how deep the ground is," says Jonathan Yewdell, M.D., Ph.D., a viral immunologist who led a team of scientists at the National Institute of Allergy and Infectious Diseases (NIAID). "This might be the 'grand canyon' of the flu, in terms of understanding this virus's virulence, or perhaps only a narrow side ravine."

The scientists turned up this new protein by accident, while sifting through bits and pieces of "junk" peptides. Junk peptides are short protein molecules the virus creates once it infects a cell and begins replicating. They form when the process that translates viral genes into proteins goes awry, Dr. Yewdell explains. In other words, junk peptides result from genetic mistakes.

"We weren't looking for new proteins at all. We assumed the 10 known influenza proteins were all there were," Dr. Yewdell says. "We just wanted to know if immune system cells had learned to recognize any of these junk peptides. We thought that was an interesting question."

The immune system cells of mice, in fact, did recognize one of the peptides. When the scientists examined the gene encoding this peptide more closely, they noticed it was "suspiciously long" for mere junk. Wondering if this molecule might be a bona fide protein, Dr. Yewdell's team decided to see how much of it was created in cells infected with the flu virus. If it were junk, there should be only a few random copies of the peptide here and there. If it were a protein, large quantities of the molecule should be present. Dr. Yewdell used a technique called immunofluorescence, which makes the molecule glow green, to show how much of it infected cells contained.

"The cells we looked at just lit up," Dr. Yewdell says. "We saw large amounts of this molecule in the mitochondria of flu infected cells, and we knew it was a real protein. It was one of those 'eureka' moments of discovery you live for in science. The junk turned out to be a jewel."

It turns out that this protein is created when ribosomes, the cellular machines that translate genes into proteins, begin reading the influenza gene called PB-1 in what was previously believed to be the wrong location. "One could say that lurking within the PB-1 gene is an overlapping gene that codes for this protein," explains Dr. Yewdell. "This alternate translation may have started out as a mistake, but the protein it produced was useful, so through evolution the gene was maintained and improved."

Tests showed the protein is toxic to human cells, especially immune system cells. "Next, we plan to learn more about the functions of this protein and how it accomplishes its tasks," Dr. Yewdell says. The team also wants to know whether this protein might have contributed to the virulence of the flu viruses that caused the Asian flu of 1957, the Hong Kong flu of 1968, and especially the Spanish flu of 1918, which killed 20 million people worldwide.

"Like many scientific discoveries, this one happened serendipitously, and it confirms the importance of supporting basic research on infectious diseases," concludes Anthony S. Fauci, M.D., NIAID director. "When you have good researchers exploring interesting questions, they are bound to turn up crucial information."

###

References:


W Chen et al. A novel influenza A virus mitochondrial protein that induces cell death. Nature Medicine 17(12):1306-12 (2001).


NIAID conducts and supports research—at NIH, throughout the United States, and worldwide—to study the causes of infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses. News releases, fact sheets and other NIAID-related materials are available on the NIAID Web site at www.niaid.nih.gov.

About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.

NIH...Turning Discovery Into Health ®

back to top


Archive

NIAID Archive

Important note: Information on this page was accurate at the time of publication. This page is no longer being updated.
​​​​

Last Updated November 30, 2001